Senior Software Engineer, Front-End

Senior Software Engineer, Full Stack

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

AB Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acutis Diagnostics

Adagio Therapeutics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

AllStripes

Alltrna

Alpine Immune Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

ALX Oncology

Alzheon

Ambagon Therapeutics

Amberstone Biosciences

Ambys Medicines

Amylyx

AN2 Therapeutics

Andes

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Ansa Biotechnologies

Antheia

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio (Flagship)

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Arbor Biotechnologies

Arcadia Science

Arcellx

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Arkuda Therapeutics

Armata Pharmaceuticals

Aro Biotherapeutics

Arpeggio Biosciences

Arrakis Therapeutics

Arranta Bio

ArsenalBio

Artisan Bio

Artiva Biotherapeutics

Aruvant

Ascidian Therapeutics

Ascribe Bioscience

Reverie Labs is pioneering technology to develop next-generation cancer therapies. Computational chemistry and machine learning provide new tools for drug discovery. Reverie is using these methods to develop small molecule kinase inhibitors to treat cancer. The process involves prediction of important molecular properties for on-target drug binding, screening millions of compounds in their virtual libraries for hit identification and molecular dynamics to understand the energetics of bound ligands to their protein targets. Reverie also uses algorithmic molecular generation to ensure selective molecules are synthesizable, stable and tissue-penetrant. With this approach, Reverie will advance a pipeline of tissue-penetrant kinase inhibitors for oncology targets.

<p>Reverie Labs is pioneering technology to develop next-generation cancer therapies. Computational chemistry and machine learning provide new tools for drug discovery. Reverie is using these methods to develop small molecule kinase inhibitors to treat cancer. The process involves prediction of important molecular properties for on-target drug binding, screening millions of compounds in their virtual libraries for hit identification and molecular dynamics to understand the energetics of bound ligands to their protein targets. Reverie also uses algorithmic molecular generation to ensure selective molecules are synthesizable, stable and tissue-penetrant. With this approach, Reverie will advance a pipeline of tissue-penetrant kinase inhibitors for oncology targets.</p>


Reverie Labs

Find a biotech startup job.